Evidence map›Paper›PMID 40896740›Full record

ArticleJournal of research in pharmacy practice

Pharmacovigilance in Practice: Insights into Knowledge, Attitudes, and Practices of Pharmacists and Pharmacy Technicians in Saudi Arabia.

Saeed Alshahrani, Majid Ali, Rama Alsreaya, Mohammed Najie, Abdulrahman Hijri, Abdulrahman Almalki, Emad Hassany, Asma Alhazmi, Bandar Mirqami, Faisal Tawhari and 5 more

Abstract read
In one paragraph

Article in Journal of research in pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Saeed AlshahraniPharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia.
Majid AliDepartment of Basic Sciences, Sulaiman Al-Rajhi University, Qassim, Saudi Arabia.
Rama AlsreayaCollege of Dentistry, Jazan University, Jazan, Saudi Arabia.
Mohammed NajieAl-Dawaa Medical Services Company, Riyadh, Saudi Arabia.
Abdulrahman HijriDepartment of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Abdulrahman AlmalkiAl-Dawaa Medical Services Company, Riyadh, Saudi Arabia.
Emad HassanyAl-Dawaa Medical Services Company, Jazan, Saudi Arabia.
Asma AlhazmiSafe Medical Company, Riyadh, Saudi Arabia.
Bandar MirqamiAl-Dawaa Medical Services Company, Riyadh, Saudi Arabia.
Faisal TawhariAl-Dawaa Medical Services Company, Riyadh, Saudi Arabia.
Yahya BajawiNahdi Medical Services Company, Wadi Aldawasir, Riyadh, Saudi Arabia.
Amirah MaashiPharmacy Practice Research Unit, Jazan University, Jazan, Saudi Arabia.
Ahmed IbrahimDepartment of Clinical Pharmacy, King Khalid University, Abha, Saudi Arabia.
Ahmed AlkazmeeniAlfarsha General Hospital, Alfarsha, Aseer Health Cluster, Saudi Arabia.
Aseel AlsreayaPharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study evaluated pharmacists' and pharmacy technicians' knowledge, attitudes, and practices (KAPs) regarding pharmacovigilance and adverse drug reaction (ADR) reporting at a tertiary care facility in Saudi Arabia. It also sought to identify the barriers to ADR reporting and propose strategies to improve pharmacovigilance practices. This study is timely given recent initiatives by the Saudi Vision 2030 to strengthen medication safety practices nationwide. Methods: A cross-sectional survey was conducted among pharmacists and pharmacy technicians at a tertiary care hospital in Saudi Arabia. A structured, self-administered questionnaire collected data on participants' KAPs regarding pharmacovigilance. Descriptive and inferential statistical analyses were conducted to identify the trends and associations between demographic variables and KAP scores. Findings: A total of 200 healthcare professionals participated in the study. While 87% of participants were aware of pharmacovigilance and 91% were familiar with ADRs, only 47.5% had ever reported an ADR. Positive attitudes were observed, with 94% agreeing that ADR reporting is an essential role of pharmacists and 90% supporting its inclusion in pharmacy curricula. However, key barriers to ADR reporting included lack of time (65%), insufficient training (58%), and uncertainty about reporting procedures (49%). Significant associations were found between knowledge levels, age, gender, and educational qualifications ( Conclusion: Despite high levels of knowledge and positive attitudes, ADR reporting practices remain suboptimal due to structural and procedural barriers. To enhance pharmacovigilance practices in Saudi Arabia, targeted training programs, simplified reporting systems, and mandatory reporting policies are recommended.

Indexed as

Adverse drug reaction reportingattitudes and practicesknowledgepharmacistspharmacovigilanceSaudi Arabia

Identifiers

PMID40896740
PMCPMC12396805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.